State Stem Cell Agency ICOC Agenda 01-30-09
Return to CIRM Meetings and Events
California State Stem Cell Agency
REGULAR MEETING OF THE
|
|
Organized Pursuant To The
|
|
Open Session |
|
[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.] |
|
Action ITEMS |
|
|
|
Closed Session |
|
|
|
ACTION ITEMS
|
|
Reports
|
|
ACTION ITEMS
|
|
10. | Consideration of loan-related terms for Disease Teams RFA. |
11. | Consideration of new scientific members for Grants Working Group. |
12. | Consideration of a public process for obtaining Board member, industry and public input regarding an update to the Scientific Strategic Plan. |
13. | Consideration of regulatory amendments to the CIRM Medical and Ethical Standards regulations, including oversight and consent requirements for use of blastocysts and somatic cells. |
14. |
Consideration of supplemental grant awards for medical school loan repayments to those physician scientists who were awarded New Faculty I and II research grants. |
DISCUSSION ITEMS |
|
Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting. | |
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE. Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
|
|
|
|
**NOTICE**
|
|
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting. Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100. This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov. |
Transcripts
Last Modified: April 5, 2017